B M Fendly

Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.

Alicia M. Viloria Petit, Janusz Rak, Mien‐Chie Hung et al. · PubMed · 1997 · 841 citations

Medicine, Cancer Biology, Oncology +17

p185 <i> ^HER2 </i> Monoclonal Antibody Has Antiproliferative Effects In Vitro and Sensitizes Human Breast Tumor Cells to Tumor Necrosis Factor

Robert M. Hudziak, Gail D. Lewis Phillips, Marcy Winget et al. · Molecular and Cellular Biology · 1989 · 663 citations · Full text

Medicine, Cancer Biology, Oncology +15

Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.

Mark X. Sliwkowski, Gabriele Schaefer, Robert W. Akita et al. · Journal of Biological Chemistry · 1994 · 644 citations · Full text

Life Sciences, Molecular Biology, Oncology +13

Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies

Gail D. Lewis Phillips, Irene S. Figari, B M Fendly et al. · Cancer Immunology Immunotherapy · 1993 · 498 citations · Full text

Medicine, Cancer Biology, Oncology +12

p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor.

R M Hudziak, M Winget, B M Fendly et al. · Molecular and Cellular Biology · 1989 · 488 citations

Medicine, Cancer Biology, Oncology +17